A Study in Benign Prostatic Hyperplasia
| Status: | Archived |
|---|---|
| Conditions: | Hematology, Benign Prostate Hyperplasia, Urology |
| Therapuetic Areas: | Hematology, Nephrology / Urology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
| End Date: | October 2011 |
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
The purpose of this trial is to evaluate the effect of tadalafil 5mg daily for 8 weeks
compared to placebo on prostatic blood perfusion in men with signs and symptoms of Benign
Prostatic Hyperplasia (BPH), measured by resistive index (RI) in the prostate transition
zone.
We found this trial at
3
sites
100 Campus Dr # 108
Scarborough, Maine 04074
Scarborough, Maine 04074
(207) 396-7600
Maine Center for Cancer Medicine and Blood Disorders - Scarborough Maine Center for Cancer Medicine...
Click here to add this to my saved trials
Click here to add this to my saved trials
New York Methodist Hospital A voluntary, acute-care teaching hospital, New York Methodist Hospital's mission is...
Click here to add this to my saved trials